slas 2022 News

Bruker launches new timsTOF-based MALDI PharmaPulse system

By The Science Advisory Board staff writers
February 8, 2022

Bruker Corporation has launched its trapped ion mobility spectronomy time-of-flight (timsTOF) matrix-assisted laser desorption/ionization (MALDI) PharmaPulse (MPP) system, a new solution for unbiased, deep, high-throughput screening (HTS) and ultra HTS (uHTS) based on label-free mass spectrometry, at the SLAS 2022 International Conference and Exhibition.

The new timsTOF MPP is the flagship of Bruker's MALDI PharmaPulse product family. The timsTOF MPP features the speed and robustness of MALDI, Bruker said. And, for the first time in HTS, the MPP takes advantage of Bruker's innovative tims technology. Tims enables rapid gas-phase separation of isobars, and even isomers, by exploiting the molecular collisional cross section. This, in combination with routine 50,000 mass resolution at full speed with quadropole time-of-flight mass spectrometry detection, enables revolutionary levels of assay specificity at HTS speed.

The timsTOF MPP features a dual MALDI/electrospray ionization ion source with a 10-kHz Smartbeam 3D laser to enable uHTS-compatible speed and throughput. The new MALDI PharmaPulse 2023 software supports a broad range of HTS applications for drug discovery, Bruker added.

Bruker's scientific instruments and analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.

The Bruker timsTOF MALDI PharmaPulse System.
The Bruker timsTOF MALDI PharmaPulse System.
Bruker acquires Prolab Instruments
Bruker has acquired Prolab Instruments, a company that specializes in low-flow, high-precision liquid chromatography technology and systems. The acquisition...
Bruker touts multiomics platform at HUPO Reconnect 2021
Bruker touted advances in collision cross section-enabled 4D proteomics workflows on the trapped ion mobility spectrometry time-of-flight (timsTOF) multiomics...
Bruker's Q2 earnings show recovery from COVID-19
Bruker's second-quarter earnings report illustrates recovery from the COVID-19 pandemic, with a 34% increase in revenue compared to the same period in...

Copyright © 2022

Last Updated ka 2/9/2022 10:00:59 AM